Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters
- 1 April 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 5 (4), 453-458
- https://doi.org/10.1093/carcin/5.4.453
Abstract
Numerous drugs, hormones and environmental pollutants induce liver growth by hypertrophy and/or hyperplasia, and promote preferential growth of putative preneoplastic foci in the liver. In the present study the regression of hyperplasia after cessation of inducer/promoter treatment was studied in normal liver and in liver foci. High doses of cyproterone acetate (CPA), a synthetic sex steroid, were administered to rats and produced a doubling of liver size; after cessation of treatment liver size declined, and 27% of the total liver DNA disappeared within 6 days. In histological sections from the involuting liver no necroses, but numerous apoptotic bodies (ABs) were found; retreatment with CPA interrupted the formation of ABs. These findings suggest that elimination of excess liver DNA after cessation of CPA treatment is due to controlled cell death by apoptosis. In a further series of experiments putative preneoplastic foci were produced by a single dose of N-nitrosomorpholine and subsequently stimulated to grow by 10 or 28 weeks of phenobarbital (PB) treatment. After withdrawal of PB numerous ABs were present in normal liver and in the foci; in both, retreatment with PB decreased the appearance of ABs. It appears that inhibition of cell death by PB may contribute to tumor promotion. Under all conditions tested more ABs were found in the foci than in non-focal parts of the liver, suggesting an enhanced cell turnover in foci. The apparent sensitivity of foci to mechanisms controlling cell death might eventually provide a means for elimination of preneoplastic lesions.This publication has 9 references indexed in Scilit:
- Response of liver foci in rats to hepatic tumor promotersToxicologic Pathology, 1982
- Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breastBritish Journal of Cancer, 1981
- ENHANCED PROLIFERATION OF PUTATIVE PRENEOPLASTIC CELLS IN RAT-LIVER FOLLOWING TREATMENT WITH THE TUMOR PROMOTERS PHENOBARBITAL, HEXACHLOROCYCLOHEXANE, STEROID COMPOUNDS, AND NAFENOPIN1981
- Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. III. Cytological changesChemico-Biological Interactions, 1980
- Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. II. Induction of growthChemico-Biological Interactions, 1980
- FEEDBACK INHIBITION OF HEPATIC DNA SYNTHESISCell Proliferation, 1980
- Enhancement of Rat Hepatocellular-Altered Foci by the Liver Tumor Promoter Phenobarbital: Evidence That Foci Are Precursors of Neoplasms and That the Promoter Acts on Carcinogen-Induced Lesions23JNCI Journal of the National Cancer Institute, 1978
- Some biochemical changes associated with nafenopin-induced liver growth in the ratBiochemical Pharmacology, 1977
- 2-STAGE CONTROL OF CELL-PROLIFERATION INDUCED IN RAT-LIVER BY ALPHA-HEXACHLOROCYCLOHEXANE1977